NCI is the nation's trusted source for cancer information
Information to help people evaluate the source and credibility of health information that they find in print or online.
Pembrolizumab is approved for mismatch repair deficient and microsatellite instability high tumors.
With our new basic search form, you can find a trial or contact the NCI for help via phone, email, or online chat.
Learn more about treatment
Supportive information on managing the physical and emotional effects of cancer and treatment for both patients and caregivers.
Information to help with talking about and coping with advanced cancer, making choices about care, and planning for the end of life.
Information on choosing a doctor or treatment facility, home care, financial help, insurance coverage, end-of-life planning, and resources to help you avoid scams.
Learn the factors associated with cancer disparities, examples of how the cancer burden differs across populations, and NCI’s role in studying, understanding, and reducing disparities.
NCI offers free information on cancer topics in English and Spanish. Get live help at 1-800-4-CANCER.
